A Randomized Pharmacogenetic Study of the Medication Topiramate in European-American Heavy Drinkers
Brief description of study
This is a 12-week, prospective, randomized clinical trial of the moderating effect of the gene rs2832407 on the efficacy of the medication topiramate in reducing drinking in 200 individuals of European descent with DSM-5 AUD. The investigators will compare the efficacy of topiramate to placebo in reducing drinking.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
Alcoholism,Alcohol Use Disorder,Alcohol
-
Age: Between 18 Years - 70 Years
-
Gender: All
Updated on
14 Jul 2023.
Study ID: 821035